Company news
Cipher Pharmaceuticals Inc. news in 2013
Cipher Pharmaceuticals Inc.'s news releases, calls and decks from 2013, newest first.
Cipher Announces Change to Board of Directors
December 30, 2013
Cipher reports record financial results for Q3 2013
October 30, 2013
Notice of Cipher Pharmaceuticals Inc. Q3 2013 Conference Call
October 22, 2013
Cipher's Partner Ranbaxy receives Paragraph IV Certification
September 19, 2013
S&P Dow Jones Indices Announces Changes to the S&P/TSX Canadian Indices
September 13, 2013
Smallcappower.com Daily Investment Idea: Canadian Stocks Beating Earnings Estimates During 2Q 2013 Include Cipher Pharmaceuticals Inc, Counsel Corp and Canfor Corp
August 16, 2013
Cipher reports record financial results for Q2 2013
July 31, 2013
Notice of Cipher Pharmaceuticals Inc. Q2 2013 Conference Call
July 17, 2013
Cipher introduces Epuris(TM) (isotretinoin) capsules in Canadian market
July 2, 2013
Cipher reports record financial results for Q1 2013
May 3, 2013
Cipher Pharmaceuticals completes Latin American distribution and supply agreement for extended-release tramadol
April 29, 2013
Notice of Cipher Pharmaceuticals Inc. Q1 2013 Conference Call and 2012 Annual and Special Meeting of Shareholders
April 15, 2013
Cipher reports record financial results for 2012
March 1, 2013
Notice of Cipher Pharmaceuticals Inc. Q4 and Year-End 2012 Conference Call
February 21, 2013
Cipher Pharmaceuticals to present at Biotech Showcase(tm) 2013
January 3, 2013